Radiopharm Theranostics (RADX)

• Market cap: $38.3M
• 1 day: -0.82%
• 5 days: -2.41%
• 1 month: -4.71%
• 3 months: -0.21%
• 6 months: -7.43%
• Year to date: -5.81%
• 1 year: 8.24%
• 5 years: -72.5%
• 10 years: -72.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Employees: 14